Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	STARD13 GIT2 TBC1D8B SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP39 TBC1D3C TBC1D3B THY1 SIPA1L1	1.24e-10	279	209	19	GO:0005096
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 FRMD7 EPS8L1 GIT2 TBC1D8B SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF2 ARHGAP39 TBC1D3C TBC1D3B THY1 SIPA1L1 RASGEF1C	3.96e-09	507	209	23	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 FRMD7 EPS8L1 GIT2 TBC1D8B SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF2 ARHGAP39 TBC1D3C TBC1D3B THY1 SIPA1L1 RASGEF1C	3.96e-09	507	209	23	GO:0030695
GeneOntologyMolecularFunction	enzyme activator activity	STARD13 NRG1 GIT2 TBC1D8B SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP39 TBC1D3C TBC1D3B PRKRA THY1 EGFR SIPA1L1	1.61e-06	656	209	22	GO:0008047
GeneOntologyMolecularFunction	enzyme regulator activity	STARD13 NRG1 FRMD7 SLCO1B3 EPS8L1 GIT2 TBC1D8B SSPOP SYDE2 ANGPTL3 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RASGRF2 ARHGAP39 TBC1D3C TBC1D3B PRKRA SLCO1B7 THY1 EGFR ABCE1 SIPA1L1 RASGEF1C	7.58e-05	1418	209	31	GO:0030234
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA1 SSPOP FGL2 HMCN2 COL11A2 COMP HAPLN1 HMCN1 AGRN	1.68e-04	188	209	9	GO:0005201
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D8B SYDE2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1	5.34e-12	109	209	14	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D8B RGMA SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B THY1 SIPA1L1 AGRN	6.30e-11	244	209	18	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TBC1D8B RGMA SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B THY1 SIPA1L1 AGRN	1.01e-08	335	209	18	GO:0043087
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	TBC1D8B RGMA SYDE2 TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B THY1 SIPA1L1 AGRN	3.58e-06	499	209	18	GO:0051345
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	NRG1 ERN1 TBC1D8B RGMA SYDE2 GNAL TBC1D3I TBC1D3G TBC1D3K ARAP2 TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ERN2 TBC1D3C TBC1D3B PPP2CA THY1 EGFR SIPA1L1 ROS1 IL1B AGRN PRLR	5.69e-06	1028	209	27	GO:0043085
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	STARD13 NRG1 FRMD7 EPS8L1 GIT2 KBTBD7 SYDE2 OGT KBTBD6 RASGRF2 ARHGAP39 PPP2CB SIPA1L1 AGRN	8.20e-06	333	209	14	GO:0051056
GeneOntologyCellularComponent	extracellular matrix	ADAM19 LAMA1 SSPOP FGL2 FCGBP HMCN2 SULF1 GLG1 ANGPTL3 C1QA COL11A2 COMP HAPLN1 ADAMTS10 HMCN1 LRIG1 AGRN OTOG	1.26e-04	656	211	18	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	ADAM19 LAMA1 SSPOP FGL2 FCGBP HMCN2 SULF1 GLG1 ANGPTL3 C1QA COL11A2 COMP HAPLN1 ADAMTS10 HMCN1 LRIG1 AGRN OTOG	1.31e-04	658	211	18	GO:0030312
Domain	TBC	TBC1D8B TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	3.87e-12	49	203	11	SM00164
Domain	RabGAP-TBC	TBC1D8B TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	9.75e-12	53	203	11	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D8B TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.50e-11	55	203	11	IPR000195
Domain	TBC_RABGAP	TBC1D8B TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.50e-11	55	203	11	PS50086
Domain	Ig-like_fold	IGSF8 NRG1 LILRB2 SPEG B2M MR1 TGM6 NCR3LG1 HMCN2 NFATC1 NFATC3 VSIG10L IGSF9 HAPLN1 LIFR THY1 HMCN1 LRIG1 IGHM ROS1 PRLR	3.00e-05	706	203	21	IPR013783
Domain	NPY4_rcpt	NPY4R2 NPY4R	1.18e-04	2	203	2	IPR001933
Domain	PKD_channel	PKD1 MCOLN2 MCOLN3	1.96e-04	11	203	3	PF08016
Domain	PKD1_2_channel	PKD1 MCOLN2 MCOLN3	1.96e-04	11	203	3	IPR013122
Domain	C8	SSPOP FCGBP OTOG	2.59e-04	12	203	3	PF08742
Domain	TIL	SSPOP FCGBP OTOG	2.59e-04	12	203	3	PF01826
Domain	IG_LIKE	IGSF8 NRG1 LILRB2 SPEG B2M MR1 NCR3LG1 HMCN2 VSIG10L IGSF9 HAPLN1 THY1 HMCN1 LRIG1 IGHM	3.21e-04	491	203	15	PS50835
Domain	Unchr_dom_Cys-rich	SSPOP FCGBP OTOG	3.34e-04	13	203	3	IPR014853
Domain	C8	SSPOP FCGBP OTOG	3.34e-04	13	203	3	SM00832
Domain	-	IGSF8 NRG1 SPEG B2M MR1 TGM6 NCR3LG1 NFATC1 NFATC3 VSIG10L IGSF9 HAPLN1 LIFR THY1 HMCN1 LRIG1 ROS1 PRLR	3.46e-04	663	203	18	2.60.40.10
Domain	KEN_dom	ERN1 ERN2	3.50e-04	3	203	2	IPR010513
Domain	PQQ	ERN1 ERN2	3.50e-04	3	203	2	PF01011
Domain	Ribonuc_2-5A	ERN1 ERN2	3.50e-04	3	203	2	PF06479
Domain	KEN	ERN1 ERN2	3.50e-04	3	203	2	PS51392
Domain	Ig-like_dom	IGSF8 NRG1 LILRB2 SPEG B2M MR1 NCR3LG1 HMCN2 VSIG10L IGSF9 HAPLN1 THY1 HMCN1 LRIG1 IGHM	4.14e-04	503	203	15	IPR007110
Domain	TIL_dom	SSPOP FCGBP OTOG	4.22e-04	14	203	3	IPR002919
Domain	VWF_type-D	SSPOP FCGBP OTOG	6.38e-04	16	203	3	IPR001846
Domain	VWFD	SSPOP FCGBP OTOG	6.38e-04	16	203	3	PS51233
Domain	VWD	SSPOP FCGBP OTOG	6.38e-04	16	203	3	SM00216
Domain	VWD	SSPOP FCGBP OTOG	6.38e-04	16	203	3	PF00094
Domain	G2F	HMCN2 HMCN1	6.95e-04	4	203	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	6.95e-04	4	203	2	PS50993
Domain	GFP	HMCN2 HMCN1	6.95e-04	4	203	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	6.95e-04	4	203	2	IPR006605
Domain	Ig_E-set	NXPE2 TGM6 NFATC1 SUOX NFATC3 UNC119B	9.60e-04	104	203	6	IPR014756
Domain	VWC_out	SSPOP FCGBP OTOG	1.08e-03	19	203	3	SM00215
Domain	PUG	ERN1 ERN2	1.15e-03	5	203	2	SM00580
Domain	NFAT	NFATC1 NFATC3	1.15e-03	5	203	2	IPR008366
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	NLE1 TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B	1.08e-07	99	152	10	M46448
Pathway	WP_GLYCOGEN_METABOLISM	AGL PYGM PPP2CA PPP2CB GYS2	2.95e-05	34	152	5	MM15985
Pathway	WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION	AGL PYGM PPP2CA PPP2CB GYS2	6.62e-05	40	152	5	M39595
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	3.15e-25	11	211	11	16863688
Pubmed	Electrical stimulation accelerates neuromuscular junction formation through ADAM19/neuregulin/ErbB signaling in vitro.	NRG1 ADAM19 EGFR	2.20e-07	3	211	3	23603262
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3G TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3B	3.49e-07	74	211	7	16625196
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	SART3 COPB2 DPYSL5 LUZP1 TOMM70 CHCHD3 FBXO3 AGL DDX54 XRN1 OGT DTNA POLE2 UBR4 CPOX OPA1 PPP2CA CSE1L GTF3C1 ABCE1 CTNNA1	5.95e-07	974	211	21	28675297
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3F TBC1D3 TBC1D3D	8.77e-07	4	211	3	12359748
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3F TBC1D3 TBC1D3D	8.77e-07	4	211	3	8406013
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 DPYSL5 BARD1 ZNF236 SSPOP ZNF462 NFATC1 SH3TC1 EXOC6B ACSF3 IGSF9 CHD6 CREB3L2 SHROOM3 OGT DTNA ARHGAP39 EVA1C GTF3C1 EGFR RASGEF1C UBA6 EHMT1 TANC1 HPS5 ZMAT1	1.40e-06	1489	211	26	28611215
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	2.18e-06	5	211	3	12604796
Pubmed	Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis.	ERN1 ERN2 PPP2CA	2.18e-06	5	211	3	23942232
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3F TBC1D3 TBC1D3D	2.18e-06	5	211	3	8471161
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	SART3 AKAP17A PHAX EIF6 CHCHD3 AGO4 FBXO3 KBTBD6 POLR2B PRKRA PPP2CA ABCE1	2.65e-06	364	211	12	24778252
Pubmed	Genetic susceptibility to febrile seizures: case-control association studies.	CNR1 SLC4A3 IL1B	7.57e-06	7	211	3	19854014
Pubmed	Defining the membrane proteome of NK cells.	IGSF8 B2M XAB2 LUZP1 TOMM70 AGO4 GLG1 DDX54 XRN1 MVP UBR4 NCAPH OPA1 PRKRA MED4 CSE1L GTF3C1 ABCE1 ANO6 GUSB LMBRD1	1.00e-05	1168	211	21	19946888
Pubmed	Type 2A protein phosphatase, the complex regulator of numerous signaling pathways.	PPM1J PPP2CA PPP2CB	1.21e-05	8	211	3	11007961
Pubmed	Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1.	B2M MR1 IGHM	1.21e-05	8	211	3	12634786
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SART3 EIF6 CHCHD3 SACS GLG1 GEMIN8 DDX54 NLE1 UNC119B SHROOM3 DTNA POLE2 POLR2B UBR4 LIFR MED4 EGFR ANO6 GUSB TRABD UBA6 EHMT1 TANC1 CTNNA1	1.36e-05	1487	211	24	33957083
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IGSF8 TANC2 SART3 COPB2 DPYSL5 LUZP1 TOMM70 SACS XRN1 C1QA OGT ARHGAP39 OPA1 HAPLN1 PRKRA PPP2CB CSE1L THY1 LRIG1 IGHM SIPA1L1 TANC1 CTNNA1	2.22e-05	1431	211	23	37142655
Pubmed	Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation.	NFATC1 IL1B	3.66e-05	2	211	2	34343639
Pubmed	NFAT-dependent and -independent exhaustion circuits program maternal CD8 T cell hypofunction in pregnancy.	NFATC1 IGHM	3.66e-05	2	211	2	34882194
Pubmed	The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.	B2M MR1	3.66e-05	2	211	2	27043408
Pubmed	The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule.	ERN1 ERN2	3.66e-05	2	211	2	22315414
Pubmed	EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.	IGSF8 EGFR	3.66e-05	2	211	2	33605506
Pubmed	High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.	NFATC1 NFATC3	3.66e-05	2	211	2	21514407
Pubmed	DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.	TMPRSS13 TMPRSS11E	3.66e-05	2	211	2	25122802
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	3.66e-05	2	211	2	11751260
Pubmed	EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner.	EGFR IL1B	3.66e-05	2	211	2	20962853
Pubmed	Constitutive activity of TRPML2 and TRPML3 channels versus activation by low extracellular sodium and small molecules.	MCOLN2 MCOLN3	3.66e-05	2	211	2	22753890
Pubmed	Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.	NRG1 EGFR	3.66e-05	2	211	2	20671236
Pubmed	JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.	B2M IGHM	3.66e-05	2	211	2	23388724
Pubmed	LRIG1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating EGFR/ERK-triggered epithelial-mesenchymal transition.	LRIG1 EGFR	3.66e-05	2	211	2	30487162
Pubmed	Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.	CNR1 EGFR	3.66e-05	2	211	2	21203460
Pubmed	Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.	EGFR ROS1	3.66e-05	2	211	2	24349229
Pubmed	Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress.	ERN1 ERN2	3.66e-05	2	211	2	11175748
Pubmed	LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance.	LRIG1 EGFR	3.66e-05	2	211	2	33947959
Pubmed	MR1 presents microbial vitamin B metabolites to MAIT cells.	B2M MR1	3.66e-05	2	211	2	23051753
Pubmed	Genetic Risk of Trigger Finger: Results of a Genomewide Association Study.	KLHL1 POLE2	3.66e-05	2	211	2	32740585
Pubmed	Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1β/NF-κB pathway.	MCOLN2 IL1B	3.66e-05	2	211	2	34548638
Pubmed	Identification of 2 Potentially Relevant Gene Mutations Involved in Strabismus Using Whole-Exome Sequencing.	AHI1 NEB	3.66e-05	2	211	2	28391287
Pubmed	Resveratrol inhibits glioma cell growth via targeting LRIG1.	LRIG1 EGFR	3.66e-05	2	211	2	29745084
Pubmed	Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.	NRG1 EGFR	3.66e-05	2	211	2	15897877
Pubmed	The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: evidence from sequence analysis and localization studies.	PPP2CA PPP2CB	3.66e-05	2	211	2	10543450
Pubmed	Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells.	NRG1 ADAM19	3.66e-05	2	211	2	17352738
Pubmed	Cell-Autonomous Role of EGFR in Spontaneous Duodenal Tumors in LRIG1 Null Mice.	LRIG1 EGFR	3.66e-05	2	211	2	33989815
Pubmed	Genetic variation in the shape of the mouse mandible and its relationship to glucocorticoid-induced cleft palate analyzed by using recombinant inbred lines.	B2M GUSB	3.66e-05	2	211	2	3732791
Pubmed	Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.	NRG1 EGFR	3.66e-05	2	211	2	27343990
Pubmed	LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.	LRIG1 EGFR	3.66e-05	2	211	2	18542056
Pubmed	Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.	PPP2CA PPP2CB	3.66e-05	2	211	2	1846293
Pubmed	Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.	PLIN1 OPA1	3.66e-05	2	211	2	21983901
Pubmed	Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.	ERN1 ERN2	3.66e-05	2	211	2	16581782
Pubmed	PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte.	PPP2CA PPP2CB	3.66e-05	2	211	2	27096707
Pubmed	Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins.	TANC2 TANC1	3.66e-05	2	211	2	21068316
Pubmed	LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.	LRIG1 EGFR	3.66e-05	2	211	2	14520461
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	3.66e-05	2	211	2	2555176
Pubmed	Regulation of epidermal growth factor receptor expression and morphology of lung epithelial cells by interleukin-1β.	EGFR IL1B	3.66e-05	2	211	2	32016419
Pubmed	Rethinking isolated cleft lip and palate as a syndrome.	IGSF9 HMCN1	3.66e-05	2	211	2	29500156
Pubmed	An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling.	ERN1 PKD1	3.66e-05	2	211	2	31167779
Pubmed	Protein phosphatases come of age.	PPM1J PPP2CA	3.66e-05	2	211	2	2557326
Pubmed	Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.	NRG1 IL1B	3.66e-05	2	211	2	17901998
Pubmed	Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.	B2M IGHM	3.66e-05	2	211	2	11123273
Pubmed	Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice.	CNR1 SIM1	3.66e-05	2	211	2	25456065
Pubmed	LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development.	LRIG1 EGFR	3.66e-05	2	211	2	23208928
Pubmed	Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.	LRIG1 EGFR	3.66e-05	2	211	2	24314030
Pubmed	Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.	LRIG1 EGFR	3.66e-05	2	211	2	29546323
Pubmed	Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.	GNAL THAP1	3.66e-05	2	211	2	31320448
Pubmed	The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation.	NRG1 EGFR	3.66e-05	2	211	2	14632199
Pubmed	Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1α and β-dependent decay and miRNA.	ERN1 ERN2	3.66e-05	2	211	2	27774654
Pubmed	Characterization of two homologs of Ire1p, a kinase/endoribonuclease in yeast, in Arabidopsis thaliana.	ERN1 ERN2	3.66e-05	2	211	2	12020828
Pubmed	α-Dystrobrevin knockout mice have increased motivation for appetitive reward and altered brain cannabinoid receptor 1 expression.	CNR1 DTNA	3.66e-05	2	211	2	36045406
Pubmed	Nrg1/ErbB signaling-mediated regulation of fibrosis after myocardial infarction.	NRG1 EGFR	3.66e-05	2	211	2	34997943
Pubmed	Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.	PPP2CA PPP2CB	3.66e-05	2	211	2	11113010
Pubmed	LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.	LRIG1 EGFR	3.66e-05	2	211	2	26159916
Pubmed	Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice.	C1QA IGHM	3.66e-05	2	211	2	17312136
Pubmed	[Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer].	MVP EGFR	3.66e-05	2	211	2	19080004
Pubmed	Activated CD8+ T Cells Cause Long-Term Neurological Impairment after Traumatic Brain Injury in Mice.	B2M IGHM	3.66e-05	2	211	2	31665632
Pubmed	Endocannabinergic modulation of interleukin-1β in mouse hippocampus under basal conditions and after in vivo systemic lipopolysaccharide stimulation.	CNR1 IL1B	3.66e-05	2	211	2	21389737
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	3.66e-05	2	211	2	32035013
Pubmed	Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities.	PPP2CA PPP2CB	3.66e-05	2	211	2	34902541
Pubmed	Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.	PPP2CA PPP2CB	3.66e-05	2	211	2	2837763
Pubmed	EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.	IGSF8 EGFR	3.66e-05	2	211	2	35773608
Pubmed	CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice.	B2M IGHM	3.66e-05	2	211	2	9815265
Pubmed	RNase domains determine the functional difference between IRE1alpha and IRE1beta.	ERN1 ERN2	3.66e-05	2	211	2	18242182
Pubmed	CB1 cannabinoid receptor deficiency promotes cardiac remodeling induced by pressure overload in mice.	CNR1 EGFR	3.66e-05	2	211	2	22656047
Pubmed	Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.	EGFR PRLR	3.66e-05	2	211	2	16785991
Pubmed	Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1.	ERN1 ERN2	3.66e-05	2	211	2	16950141
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	AKAP17A COPB2 DPYSL5 XAB2 ZNF462 FBXO3 SACS CHD6 MVP OGT POLR2B ARHGAP39 SIM1 OPA1 PRKRA CSE1L GTF3C1 EHMT1 AGRN	3.70e-05	1082	211	19	38697112
Pubmed	Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin.	B2M ABCD2 IGHM	4.65e-05	12	211	3	12150895
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SART3 COPB2 EIF6 XAB2 DDX54 XRN1 NLE1 MVP UBR4 PRKRA CSE1L GTF3C1 ABCE1 CTNNA1	5.10e-05	653	211	14	22586326
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NRG1 ACACB SPEG DPYSL5 NEB DDX54 RASGRF2 POLR2B OPA1 GTF3C1 UBA6 CTNNA1	5.79e-05	497	211	12	36774506
Pubmed	Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity.	B2M THY1 IGHM	7.63e-05	14	211	3	25968334
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 SART3 COPB2 EIF6 NT5DC1 LUZP1 CHCHD3 DDX54 XRN1 NLE1 TAF2 MVP POLR2B UBR4 NCAPH PRKRA CSE1L GTF3C1 ABCE1 TANC1 AGRN	8.41e-05	1353	211	21	29467282
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 MAGI1 GIT2 LUZP1 ZNF462 NFATC3 SHROOM3 OGT UBR4 ARHGAP39 OPA1 PPP2CB SIPA1L1 UBA6 EHMT1 CTNNA1 AGRN	9.01e-05	963	211	17	28671696
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	COPB2 NFATC1 GEMIN8 AGL DDX54 OGT KBTBD6 POLR2B OPA1 PPP2CA PPP2CB TRABD TMLHE	9.41e-05	606	211	13	36538041
Pubmed	High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes.	PLIN1 CNR1 NPY4R	9.49e-05	15	211	3	18719666
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	B2M EPS8L1 EIF6 GGT1 GGT3P FGL2 FCGBP GLG1 PYGM GNAL COMP LIFR THY1 HMCN1 ANO6 GUSB IGHM AGRN	1.02e-04	1070	211	18	23533145
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SART3 MAML1 FRMD4B AGO4 SULF1 AP5Z1 IGSF9 SHROOM3 NCAPH PLCH2 EHMT1 HPS5	1.04e-04	529	211	12	14621295
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	1.09e-04	3	211	2	12388743
Pubmed	Relationships of gamma-glutamyltransferase and beta 2-microglobulin on high sensitivity C-reactive protein among Japanese elementary school children.	B2M GGT1	1.09e-04	3	211	2	24572983
Pubmed	ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes.	NFATC1 IL1B	1.09e-04	3	211	2	19052845
Pubmed	Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.	NRG1 EGFR	1.09e-04	3	211	2	31382039
Pubmed	Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination.	LIFR EGFR	1.09e-04	3	211	2	15385618
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	NLE1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	5.93e-12	149	211	12	chr17q12
Cytoband	17q12	NLE1 TBC1D3F TBC1D3 TBC1D3H TBC1D3C TBC1D3B	6.89e-06	99	211	6	17q12
Cytoband	12p12.2	SLCO1B7 GYS2	2.08e-04	5	211	2	12p12.2
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC3	5.53e-04	5	136	2	665
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NRG1 SPEG HMCN2 IGSF9 HMCN1 LRIG1	1.38e-03	161	136	6	593
GeneFamily	Fibulins	HMCN2 HMCN1	1.53e-03	8	136	2	556
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TANC2 TOMM70 SH3TC1 OGT TANC1	1.77e-03	115	136	5	769
GeneFamily	Ankyrin repeat domain containing	TANC2 BARD1 GIT2 ANKRD53 ARAP2 EHMT1 TANC1	2.39e-03	242	136	7	403
GeneFamily	C1-set domain containing	B2M MR1 NCR3LG1	3.86e-03	42	136	3	591
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP2CA PPP2CB	4.15e-03	13	136	2	693
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT11 FUT3	4.15e-03	13	136	2	434
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT1 GGT3P	4.15e-03	13	136	2	564
GeneFamily	WD repeat domain containing\|GRAM domain containing\|BEACH domain containing	TBC1D8B GRAMD1C	4.15e-03	13	136	2	1146
Coexpression	LIM_MAMMARY_STEM_CELL_UP	NRG1 AHI1 LAMA1 LUZP1 FGL2 SH3TC1 SULF1 PKD1 LARGE2 GJC1 SLC4A3 LIFR THY1 EGFR PLCH2 IL1B	1.39e-06	479	206	16	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	NRG1 AHI1 LAMA1 LUZP1 FGL2 SH3TC1 SULF1 PKD1 LARGE2 GJC1 SLC4A3 LIFR THY1 EGFR PLCH2 IL1B	1.55e-06	483	206	16	MM1082
Coexpression	NABA_CORE_MATRISOME	VWA5B2 LAMA1 SSPOP FGL2 HMCN2 COL11A2 COMP HAPLN1 HMCN1 AGRN OTOG	1.04e-05	270	206	11	MM17057
Coexpression	NABA_CORE_MATRISOME	VWA5B2 LAMA1 SSPOP FGL2 HMCN2 COL11A2 COMP HAPLN1 HMCN1 AGRN OTOG	1.24e-05	275	206	11	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	VWA5B2 LAMA1 SSPOP FGL2 HMCN2 COMP HMCN1 AGRN OTOG	2.16e-05	191	206	9	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	VWA5B2 LAMA1 SSPOP FGL2 HMCN2 COMP HMCN1 AGRN OTOG	2.64e-05	196	206	9	M3008
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	EPS8L1 GGT1 RGMA NFATC1 TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.38e-07	213	202	13	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	EPS8L1 GGT1 RGMA NFATC1 TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.38e-07	213	202	13	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.94e-07	90	202	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	EPS8L1 RGMA NFATC1 SUOX TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	5.97e-07	242	202	13	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	LAMA1 GGT1 RGMA AGL TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B LIFR	2.52e-06	320	202	14	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	PVRIG TBC1D3G TBC1D3K TBC1D3F LARGE2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ADAMTS10 AGRN	3.15e-06	281	202	13	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	PVRIG TBC1D3G TBC1D3K TBC1D3F LARGE2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ADAMTS10 AGRN	3.15e-06	281	202	13	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	ADAM19 LAMA1 ABHD3 PPM1J AGO4 NFATC1 AGL PVRIG GMPR GNAL TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D DTNA ARHGAP39 TBC1D3C TBC1D3B LIFR SLC2A4RG B3GNT2 AGRN LMBRD1	3.93e-05	1153	202	26	PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L1 NXPE2 AGL DDX54 IGSF9 UNC119B PPP2CB GRAMD1C MCOLN3	8.86e-08	163	211	9	7a04192710f55acf5a4681d5f09942358fdb02ff
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB IP6K3 GLG1 GMPR EVA1C LIFR EGFR ZMAT1 PRLR	3.12e-07	189	211	9	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 TANC2 MAGI1 EXOC6B CCSER1 SHROOM3 EGFR SIPA1L1 TANC1	4.61e-07	198	211	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	STARD13 EPS8L1 PPM1J GALR2 ABCD2 MCOLN2 DTNA SLC4A3	9.47e-07	159	211	8	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	Healthy_Control-Lymphoid-B-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ADAM19 TMEM156 HMCN2 PYGM COMP PLCH2 IGHM GRAMD1C	1.14e-06	163	211	8	d84bd41b4494c7d5c7f88d511bfe481fb12f079d
ToppCell	Healthy_Control-Lymphoid-B\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ADAM19 TMEM156 HMCN2 PYGM COMP PLCH2 IGHM GRAMD1C	1.14e-06	163	211	8	0f723ec2503afa1b3ebb0754972438ffb6e6179d
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GALR2 PLIN1 COL11A2 COMP HAPLN1 TMLHE RFLNA MCOLN3	1.94e-06	175	211	8	f1394aacc8a94ca555dd19aaed5a18da99c6bf40
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GALR2 PLIN1 COL11A2 COMP HAPLN1 TMLHE RFLNA MCOLN3	1.94e-06	175	211	8	7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 FGL2 FCGBP PYGM THAP1 THY1 CCM2L EGFR	2.12e-06	177	211	8	767b2af5f224d100b22bed32f86cec1cd17e8711
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 FGL2 FCGBP PYGM THAP1 THY1 CCM2L EGFR	2.12e-06	177	211	8	5ef2527e9b41e62f1724cdabaad9d8979266bb7d
ToppCell	E18.5-Endothelial-Endothelial_lymphatic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 FGL2 FCGBP PYGM THAP1 THY1 CCM2L EGFR	2.12e-06	177	211	8	ae1d2fdd4f67f50c906b27ea084de058c6908aa2
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 FGL2 FCGBP PYGM THAP1 THY1 CCM2L EGFR	2.12e-06	177	211	8	8dfadd9852e0c256363471a7cfe6af120c8c51e0
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MAGI1 ADAM19 NEB EXOC6B CCSER1 DTNA SLC4A3 TANC1	3.31e-06	188	211	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FGL2 FCGBP MROH7 MCOLN2 CCSER1 ADAMTS10 LRIG1	5.50e-06	143	211	7	5a279da1cd8e63db32f7c85a73b493c2121d0a96
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FGL2 FCGBP MROH7 MCOLN2 CCSER1 ADAMTS10 LRIG1	6.03e-06	145	211	7	997bd540c43725a85ca97e4b79ebe0d336860287
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DPYSL5 BARD1 PPM1J GSX2 EVA1C HMCN1 EGFR	8.58e-06	153	211	7	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3\|Liver / Manually curated celltypes from each tissue	ADAM19 ACACB SYDE2 IGSF9 COL11A2 EVA1C THY1	1.30e-05	163	211	7	7f61483eeb1fde21843c6391468e13cb0cc2a89f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SH3TC1 GMPR CCSER1 SHROOM3 TMPRSS11E PRLR	1.35e-05	164	211	7	d847d509bb1791638032ade6755d8164586b5bd5
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SH3TC1 GMPR CCSER1 SHROOM3 TMPRSS11E PRLR	1.46e-05	166	211	7	6fe8db8d45177a78605681f22e04fa8d0594f2df
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MR1 FGL2 GJC1 HMCN1 FAM169A ZNF654	1.65e-05	113	211	6	ec4b89e727e1b921b9cb17443774955b95814dd4
ToppCell	droplet-Kidney-nan-21m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALR2 GGT1 ANGPTL3 COMP HAPLN1 EVA1C PRLR	1.77e-05	171	211	7	007f148f4611ea1826edfa9f91ced36541ad9f5a
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC-DC1\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	VWA5B2 PPM1J FGL2 ABCD2 MCOLN2 CCSER1 SLC4A3	2.05e-05	175	211	7	398e2504021f587166ad04a2f0662bfcb4e1c0df
ToppCell	10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAM19 ERN1 CSMD2 ZNF462 ABCD2 TMPRSS11E TBC1D3B	2.13e-05	176	211	7	f0c01fc4f9c17c4d724642d9931731eef2b10258
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMA1 SULF1 COL11A2 COMP TBC1D3D HAPLN1 RFLNA	2.21e-05	177	211	7	b01d7a6a78169962123ddfb0bb588f51d138ad02
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GLG1 MCOLN2 COL11A2 TBC1D3 COMP HAPLN1 SIPA1L1	2.64e-05	182	211	7	00a148b1e499bf16325491536d187d4dd6b70c06
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERN1 TMEM156 XRN1 CREB3L2 OGT IGHM EHMT1	2.93e-05	185	211	7	3b77bc49cd3740acc025e162a36282ac09e12198
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NAB1 MAML1 FRMD4B SH3TC1 GLG1 NCAPH FAM169A	3.13e-05	187	211	7	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	wk_08-11-Hematologic-Myeloid-DC1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PPM1J FGL2 TMEM156 TBC1D3G MVP MCOLN2 CCSER1	3.13e-05	187	211	7	2907cc0b8789c5e1468917caa21fa0feb025305e
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 MAGI1 ACACB EXOC6B GMPR SIM1 LIFR	3.47e-05	190	211	7	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MAGI1 ACACB EXOC6B CCSER1 DTNA SLC4A3 STK33	3.47e-05	190	211	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 RGMA SHOX LIFR THY1 HMCN1 EGFR	3.83e-05	193	211	7	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	NRG1 B2M FRMD4B RASGRF2 EVA1C LIFR HMCN1	3.83e-05	193	211	7	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 RGMA SHOX LIFR THY1 HMCN1 EGFR	3.83e-05	193	211	7	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 RGMA SHOX LIFR THY1 HMCN1 EGFR	3.83e-05	193	211	7	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	LAM-Myeloid-DC\|Myeloid / Condition, Lineage and Cell class	ADAM19 PPM1J FRMD4B FGL2 TMEM156 FCGBP CCSER1	3.83e-05	193	211	7	f665cce40053ae5d6e28f9f70ddf78e8598c9514
ToppCell	distal-2-Hematologic-Myeloid_Dendritic_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRB2 GALR2 FGL2 TMEM156 SACS MCOLN2 CCSER1	3.96e-05	194	211	7	6881cfe12837a32e598535a564e4c31d4846167b
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA1 CSMD2 HMCN2 SULF1 SHROOM3 HMCN1 IL1B	4.09e-05	195	211	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRB2 GALR2 FGL2 TMEM156 SACS MCOLN2 CCSER1	4.09e-05	195	211	7	7606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA1 CSMD2 HMCN2 SULF1 SHROOM3 HMCN1 IL1B	4.09e-05	195	211	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FRMD7 DPYSL5 PPM1J CNR1 EVA1C GYS2	4.14e-05	133	211	6	840e8240db29cd21ed9830843c0fa6d65b8f300a
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 TANC2 MAGI1 EXOC6B CCSER1 SHROOM3 SIPA1L1	4.23e-05	196	211	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADAM19 TMEM156 NFATC1 SACS MCOLN2 TRABD IGHM	4.23e-05	196	211	7	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	ADAM19 ERN1 FRMD4B LUZP1 SH3TC1 OGT LRIG1	4.23e-05	196	211	7	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	wk_08-11-Hematologic-Myeloid-APOE+_Mac1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LILRB2 B2M FGL2 PER3 NFATC1 C1QA OPLAH	4.37e-05	197	211	7	121ec3f6d978de2f6c2cc397f7327d2e5587ab8b
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PPM1J FGL2 C1QA MCOLN2 CCSER1 SLC4A3 HPS5	4.37e-05	197	211	7	81dd7f9318f0ba175352e5156c24772427e0b34f
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 SPEG HMCN2 SACS SULF1 DTNA GJC1	4.37e-05	197	211	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TANC2 FRMD4B COMP RASGRF2 DTNA HMCN1 TANC1	4.37e-05	197	211	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	XAB2 GEMIN8 COMP KBTBD6 CPOX SIM1	4.50e-05	135	211	6	641d42a005ff61f21e6cda02bfbd0bd1d4ba2faa
ToppCell	Biopsy_IPF-Immune-pDCs\|Biopsy_IPF / Sample group, Lineage and Cell type	ADAM19 ERN1 PPM1J ANKRD53 MCOLN2 SLC4A3 IGHM	4.51e-05	198	211	7	aa8943e6796f619406056cf763b751fe9a9a3e0c
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 PPM1J FGL2 MCOLN2 CCSER1 SLC4A3 HPS5	4.65e-05	199	211	7	26ea06960e8ea061a71756750b84489609f78162
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MROH7 PYGM ABCD2 PLIN1 DTNA LRIG1 GRAMD1C	4.80e-05	200	211	7	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	Macroglial-Astrocytes-GFAP---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 GMPR PLIN1 SHROOM3 DTNA LRIG1 CYP4F12	4.80e-05	200	211	7	88d66550781a3c9102ff7455f5cff6fb072943cd
ToppCell	Macroglial-Astrocytes-GFAP-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 GMPR PLIN1 SHROOM3 DTNA LRIG1 CYP4F12	4.80e-05	200	211	7	d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCell	Macroglial-Astrocytes-GFAP--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 GMPR PLIN1 SHROOM3 DTNA LRIG1 CYP4F12	4.80e-05	200	211	7	16269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCell	Sepsis-Int-URO-Myeloid-cDC1\|Int-URO / Disease, condition lineage and cell class	PPM1J EIF6 ZNF462 CHCHD3 CCSER1 STK33 HPS5	4.80e-05	200	211	7	77479f733cc4ce62a07ab33d5dc2d41c911c74fc
ToppCell	Macroglial-Astrocytes-GFAP\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 GMPR PLIN1 SHROOM3 DTNA LRIG1 CYP4F12	4.80e-05	200	211	7	79634b1086934412ae92f259ab43554ce545008f
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ACACB LAMA1 ABCD2 SHROOM3 DTNA LRIG1 GRAMD1C	4.80e-05	200	211	7	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 SPEG HMCN2 SACS SULF1 DTNA GJC1	4.80e-05	200	211	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Macroglial-Astrocytes-GFAP----L1-2\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 GMPR PLIN1 SHROOM3 DTNA LRIG1 CYP4F12	4.80e-05	200	211	7	c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCell	Biopsy_Other_PF-Immune-cDCs\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ADAM19 FGL2 FCGBP MCOLN2 CCSER1 SIPA1L1 HPS5	4.80e-05	200	211	7	8e455f685f0a9c63e83d6d339d7767f0e9841c6e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MROH7 PYGM ABCD2 PLIN1 DTNA LRIG1 GRAMD1C	4.80e-05	200	211	7	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ABHD3 RGMA DTNA HAPLN1 EVA1C LIFR LRIG1	4.80e-05	200	211	7	792fef1f3e47ce5c131fedfad55075fc254aeead
ToppCell	COVID-19_Moderate-B_cell\|World / disease group, cell group and cell class	PER3 TBC1D3L TMPRSS11E IGHM STK33 GRAMD1C	5.30e-05	139	211	6	b93e1da87d44e55d75e8cc1b87c2970645679c01
ToppCell	BAL-Control-cDC_4\|Control / Compartment, Disease Groups and Clusters	TBC1D8B MROH7 CCSER1 EVA1C LRIG1 TRABD	6.70e-05	145	211	6	3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8
ToppCell	Dendritic_Cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ADAM19 PPM1J FGL2 PYGM ABCD2 MCOLN2	8.38e-05	151	211	6	e089bf197ed60e7243160521d4390d4b40a3832b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|GI_small-bowel / Manually curated celltypes from each tissue	MAGI1 IGSF9 CCSER1 KBTBD6 STK33 CCDC171	9.68e-05	155	211	6	1c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAM19 TMEM156 MCOLN2 CCSER1 NCAPH TRABD	9.68e-05	155	211	6	9f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B2M PPM1J FGL2 MCOLN2 SIM1 THY1	9.68e-05	155	211	6	d8e9f355ce933f6383c3d1e35ff55235a95c7fcd
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B2M PPM1J FGL2 MCOLN2 SIM1 THY1	1.08e-04	158	211	6	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NRG1 ZGRF1 ZNF462 OGT EVA1C ZFAND1	1.08e-04	158	211	6	6d2709b387945c015faa223c20d22b52a4082140
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	STARD13 EPS8L1 PPM1J GALR2 DTNA SLC4A3	1.11e-04	159	211	6	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DPYSL5 SYDE2 CHD6 CNR1 HAPLN1 EGFR	1.11e-04	159	211	6	7f29f9dcf25ffa1822b137c571e9ac16defc6292
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LILRB2 B2M GALR2 FGL2 TRAV41 IL1B	1.11e-04	159	211	6	210ac7fa89514a84f38d9f42254e38fbc2bc5f42
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LILRB2 B2M GALR2 FGL2 TRAV41 IL1B	1.15e-04	160	211	6	c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 GIT2 TMEM156 SH3TC1 IGHM	1.19e-04	101	211	5	86acaa2502f61baa714ae988b73e3e73a71e897e
ToppCell	facs-Kidney-nan-3m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZGRF1 BARD1 PPM1J FGL2 POLN THY1	1.28e-04	163	211	6	385b24e18df5ef92108483de312d6c85a1e6d145
ToppCell	facs-Kidney-nan-3m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZGRF1 BARD1 PPM1J FGL2 POLN THY1	1.28e-04	163	211	6	8004cc0b3428be08b89957b563cd8799f822d931
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	C12orf56 NEB SYDE2 HAPLN1 EGFR	1.36e-04	104	211	5	b5ca6e589f414e549f4990fe334d4ee54829b298
ToppCell	normal_Lung-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	NCR3LG1 FRMD4B FGL2 NCAPH GYS2 IL1B	1.41e-04	166	211	6	07b498eb341abec02a3ccaae320bdbb5cd6883c5
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE2 GGT1 AGL IGSF9 UNC119B GRAMD1C	1.46e-04	167	211	6	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GALR2 MCOLN2 COL11A2 COMP HAPLN1 RFLNA	1.46e-04	167	211	6	102b3d160a44c8623fab1fd10e9054178c42a78b
ToppCell	facs-Trachea-nan-18m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IP6K3 GALR2 COL11A2 COMP HAPLN1 RFLNA	1.46e-04	167	211	6	7b1fd19946cee67dae68f0f0d98420abcd532482
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE2 GGT1 AGL IGSF9 UNC119B GRAMD1C	1.46e-04	167	211	6	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ADAM19 LILRB2 FCGBP C1QA HMCN1 CYP4F12	1.50e-04	168	211	6	d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	SPEG NXPE2 SULF1 RASGRF2 CCM2L HMCN1	1.50e-04	168	211	6	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MAGI1 NRG1 SYDE2 TBC1D3C EGFR IGHM	1.55e-04	169	211	6	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSPOP SH3TC1 EXOC6B UNC119B RFLNA HPS5	1.55e-04	169	211	6	46f0f0de9a0894c454f93032e7a7a800f47c8276
ToppCell	NS-critical-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NXPE2 FCGBP IGSF9 ERN2 EVA1C EGFR	1.55e-04	169	211	6	aec97583b23112060437b619cb429dc32f29285f
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GGT1 LARGE2 POLE2 THY1 LRIG1 PLCH2	1.55e-04	169	211	6	1de3ae36d3b60e961bfd9f7bdc37867b82a0417f
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LILRB2 FGL2 FCGBP C1QA HMCN1 CYP4F12	1.55e-04	169	211	6	d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALR2 ANGPTL3 COMP HAPLN1 EVA1C PRLR	1.66e-04	171	211	6	8e7223ba447947cdf4e1c82a52fd90439cf3d8f6
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZGRF1 BARD1 SACS POLE2 PCDHB2 ZNF654	1.76e-04	173	211	6	20889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 ADAM19 POLN ABCD2 THY1 IL1B	1.76e-04	173	211	6	cd635751f999e12b14c0accfa1c4c1fd3c1d4540
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZGRF1 BARD1 SACS POLE2 PCDHB2 ZNF654	1.76e-04	173	211	6	46e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 ADAM19 POLN ABCD2 THY1 IL1B	1.76e-04	173	211	6	7456a417c5c1d4ba25f9489065aae322421308a6
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 ADAM19 POLN ABCD2 THY1 IL1B	1.76e-04	173	211	6	35586a9e5f15b41609b6224e33eb3aa3cb7e03b7
ToppCell	Leuk-UTI-Myeloid-cDC1\|Leuk-UTI / Disease, Lineage and Cell Type	PPM1J MCOLN2 CCSER1 MFSD2B SLC4A3 HPS5	1.76e-04	173	211	6	226bb8d881f32d65c60f5e4c034c6d465f8e7ba5
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_11\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADAM19 PPM1J FGL2 ZNF462 MCOLN2 CCSER1	1.82e-04	174	211	6	c8cec89369cf3896c5626e447051e76a142cb6df
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_11\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADAM19 PPM1J FGL2 ZNF462 MCOLN2 CCSER1	1.82e-04	174	211	6	991f7eab69ea3ee1045a4e44ce60a96db13df6d1
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	MAML1 PPM1J GGT1 OPLAH MCOLN2 IGHM	1.82e-04	174	211	6	69723f5666abc3af5f0431901a60246c9915ef81
Disease	Writer's Cramp	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C4316810
Disease	Dystonia Disorders	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0393593
Disease	Idiopathic familial dystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0393598
Disease	Adult-Onset Idiopathic Focal Dystonias	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752198
Disease	Adult-Onset Dystonias	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752197
Disease	Adult-Onset Idiopathic Torsion Dystonias	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752199
Disease	Autosomal Dominant Familial Dystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752200
Disease	Childhood Onset Dystonias	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752202
Disease	Autosomal Recessive Familial Dystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752201
Disease	Dystonia, Primary	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752203
Disease	Dystonias, Sporadic	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752206
Disease	Dystonia, Secondary	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752205
Disease	Pseudodystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752208
Disease	Familial Dystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0752207
Disease	Focal Dystonia	GNAL THAP1 PRKRA	1.05e-05	7	200	3	C0743332
Disease	Pancreatic Ductal Adenocarcinoma	ADAM19 ACACB ABCD2	4.86e-05	11	200	3	C1335302
Disease	Marijuana Abuse	NRG1 CNR1 EGFR IL1B	4.89e-05	30	200	4	C0024809
Disease	mucolipidosis type IV (implicated_via_orthology)	MCOLN2 MCOLN3	1.37e-04	3	200	2	DOID:0080490 (implicated_via_orthology)
Disease	Disproportionate short stature	SULF1 COL11A2 COMP SHOX LIFR	1.81e-04	77	200	5	C0878659
Disease	Dystonia, Limb	GNAL THAP1 PRKRA	1.94e-04	17	200	3	C0751093
Disease	Dystonia, Diurnal	GNAL THAP1 PRKRA	1.94e-04	17	200	3	C0393610
Disease	Dystonia, Paroxysmal	GNAL THAP1 PRKRA	2.32e-04	18	200	3	C0393588
Disease	level of leucine-rich repeats and immunoglobulin-like domains protein 1 in blood serum	MAGI1 LRIG1	2.72e-04	4	200	2	OBA_2042226
Disease	glycoproteinosis (implicated_via_orthology)	MCOLN2 MCOLN3	2.72e-04	4	200	2	DOID:3343 (implicated_via_orthology)
Disease	osteochondrodysplasia (is_implicated_in)	COL11A2 COMP LIFR	2.74e-04	19	200	3	DOID:2256 (is_implicated_in)
Disease	inflammatory bowel disease (is_implicated_in)	B2M EGFR ANO6	2.74e-04	19	200	3	DOID:0050589 (is_implicated_in)
Disease	blood urea nitrogen measurement	NRG1 ZNF462 NFATC1 NFATC3 SHROOM3 SIM1 EGFR TANC1 HPS5 CCDC171 PRLR	2.81e-04	452	200	11	EFO_0004741
Disease	Dystonia	MR1 SUOX GNAL THAP1 PRKRA	3.04e-04	86	200	5	C0013421
Disease	Orofacial cleft	TANC2 NRG1 OR9K2 LRIG1	3.99e-04	51	200	4	HP_0000202
Disease	bilirubin metabolic disorder (implicated_via_orthology)	SLCO1B3 SLCO1B7	4.51e-04	5	200	2	DOID:2741 (implicated_via_orthology)
Disease	Glycogen Storage Disease	AGL PYGM GYS2	7.96e-04	27	200	3	C0017919
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT1 GGT3P	9.39e-04	7	200	2	DOID:5022 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	ADAM19 LAMA1 SLCO1B3 NFATC1 SH3TC1 SACS ABCD2 RASGRF2 HAPLN1 LIFR CSE1L EGFR ABCE1	1.07e-03	702	200	13	C0009402
Disease	chronic kidney disease	NRG1 PPM1J NFATC1 AGL CCSER1 SHROOM3 LRIG1	1.16e-03	235	200	7	EFO_0003884
Disease	alcohol dependence (biomarker_via_orthology)	GGT1 GGT3P	1.25e-03	8	200	2	DOID:0050741 (biomarker_via_orthology)
Disease	deoxycholic acid glucuronide measurement	SLCO1B3 TMPRSS11E	1.25e-03	8	200	2	EFO_0800575
Disease	fatty liver disease (biomarker_via_orthology)	SUOX OPA1 IL1B	1.44e-03	33	200	3	DOID:9452 (biomarker_via_orthology)
Disease	systolic blood pressure, body mass index	NCR3LG1 RFLNA LMBRD1	1.57e-03	34	200	3	EFO_0004340, EFO_0006335
Disease	angiotensin-converting enzyme measurement	TANC2 NRG1	1.59e-03	9	200	2	EFO_0006515
Disease	gamma-glutamylisoleucine measurement	LILRB2 GGT1	1.59e-03	9	200	2	EFO_0021139
Disease	hexadecenedioate (C16:1-DC) measurement	SLCO1B3 SLCO1B7	1.59e-03	9	200	2	EFO_0800562
Disease	aortic valve stenosis (is_marker_for)	NFATC1 OGT	2.42e-03	11	200	2	DOID:1712 (is_marker_for)
Disease	chronic kidney disease (implicated_via_orthology)	SHROOM3 IL1B	2.89e-03	12	200	2	DOID:784 (implicated_via_orthology)
Disease	stenosing tenosynovitis	KLHL1 POLE2	2.89e-03	12	200	2	EFO_0010822
Disease	Colorectal Neoplasms	LAMA1 SLCO1B3 SH3TC1 ABCD2 HAPLN1 EGFR ABCE1	2.93e-03	277	200	7	C0009404
Disease	fructose measurement	NRG1 UBR4	3.39e-03	13	200	2	EFO_0010477
Disease	glycochenodeoxycholate glucuronide (1) measurement	SLCO1B3 SLCO1B7	3.39e-03	13	200	2	EFO_0800474
Disease	rhinitis (biomarker_via_orthology)	OPA1 IL1B	3.39e-03	13	200	2	DOID:4483 (biomarker_via_orthology)
Disease	Connective Tissue Diseases	PKD1 COL11A2	3.39e-03	13	200	2	C0009782
Disease	Gastric Adenocarcinoma	ERN1 SPEG ROS1	3.53e-03	45	200	3	C0278701
Disease	Degenerative polyarthritis	MVP COMP OPA1 IL1B	3.74e-03	93	200	4	C0029408
Disease	Osteoarthrosis Deformans	MVP COMP OPA1 IL1B	3.74e-03	93	200	4	C0086743
Disease	Heart Diseases	B2M SLC4A3 PPP2CA	3.76e-03	46	200	3	C0018799
Disease	median neuropathy (biomarker_via_orthology)	NRG1 EGFR	3.94e-03	14	200	2	DOID:571 (biomarker_via_orthology)
Disease	glycerate measurement	HMCN1 AGRN	4.53e-03	15	200	2	EFO_0021029
Disease	ceramide measurement	STARD13 ADAM19 SLCO1B3 ERN2 SLCO1B7 CCDC171	5.49e-03	235	200	6	EFO_0010222
Disease	Glycogen storage disease	AGL PYGM	5.81e-03	17	200	2	cv:C0017919
Disease	Cannabis Dependence	NRG1 CNR1	5.81e-03	17	200	2	C0006870
Disease	diabetic neuropathy (biomarker_via_orthology)	NRG1 IL1B	5.81e-03	17	200	2	DOID:9743 (biomarker_via_orthology)
Disease	X-21441 measurement	SLCO1B3 SLCO1B7	5.81e-03	17	200	2	EFO_0800814
Disease	Limb Deformities, Congenital	COL11A2 HAPLN1	5.81e-03	17	200	2	C0206762
Disease	diabetic retinopathy (is_marker_for)	GGT1 EGFR IL1B	5.90e-03	54	200	3	DOID:8947 (is_marker_for)
Disease	Gastric ulcer	NRG1 IL1B	6.51e-03	18	200	2	C0038358
Disease	maximum cigarettes per day measurement	NFATC1 EGFR	6.51e-03	18	200	2	EFO_0009264

Protein segments in the cluster

Peptide	Gene	Start	Entry
TPTEKDEYACRVNHV	B2M	91	P61769
DEYACRVNHVTLSQP	B2M	96	P61769
YPSDLRDALHSQCVA	SLC4A3	696	P48751
AHVRDQTCVSTYLPR	ADAM5	286	Q6NVV9
THLPDTERLIADYAC	GRAMD1C	76	Q8IYS0
TINTVAYHARPDSDQ	BARD1	716	Q99728
RYETITLQSDHCLDP	CSMD2	856	Q7Z408
HFVYQAVPRTSATQC	CSMD2	1721	Q7Z408
EEPYQNHSGRFVCTV	C1QA	141	P02745
AYPAAENTEILHCTE	ABCD2	56	Q9UBJ2
CNHQVDTAPTVVALY	AHI1	1046	Q8N157
NPQTTTRKLEDHCFY	ADAM19	101	Q9H013
EAHSDYIRCIAVHPT	COPB2	96	P35606
ECIPLHSSRSITYVE	CCDC171	921	Q6TFL3
CNDTIPEDYETHQLR	COMP	741	P49747
EACSVGIPYHDREAN	GYS2	136	P54840
NVDPVQHTYSCKVRV	AGRN	56	O00468
SRFLQDHCPVVTETY	ABHD3	66	Q8WU67
TVAISDAAQLPHDYC	EIF4EBP2	21	Q13542
ADIICEYPDIHQSSR	POLE2	346	P56282
HDSYIPCSERIHVAV	GIT2	666	Q14161
SENPQREACSYTIHA	ACSF3	391	Q4G176
AIRPSNSQVFHVYCD	ANGPTL3	261	Q9Y5C1
KDYHVPSSDQNICIE	ARAP2	91	Q8WZ64
STEVCSPRYHRDANT	AP5Z1	771	O43299
LHPSVCREDSYHSVV	CCSER1	531	Q9C0I3
DGHPSRYCATVRVQT	AGO4	611	Q9HCK5
RIPTHEIAAASYLQD	CCM2L	131	Q9NUG4
ECDPRHYQQRTLTFA	DCPS	306	Q96C86
ECRNQLDSSAVAPHY	ADAMTS10	851	Q9H324
SDDPCIYIQIEHSAI	POLN	276	Q7Z5Q5
DNLRHDPEASVCIYA	MROH7	1246	Q68CQ1
DYECRSHNVDLPESR	ARHGAP39	6	Q9C0H5
EASPVLAARQDVAYH	LARGE2	476	Q8N3Y3
CNSFLRHARETPDSY	NRG1	401	Q02297
AQASCQPRHYSVAEE	PCDHB2	26	Q9Y5E7
PQDYTRISSLNSVHC	ACACB	1866	O00763
AVDCVIYLSQHISPA	ACACB	2426	O00763
EQARPEYEARCTHVV	ANO6	416	Q4KMQ2
VIHRDNTTVALPCIY	ANKRD53	181	Q8N9V6
SRAVDHFYCDSRPLQ	OR9K2	196	Q8NGE7
KEPDNHVYTRAAVAA	GGT3P	31	A6NGU5
HCTQAYPVRTAGQEL	MAML1	956	Q92585
EAYVHDAPVRSLNCT	IL1B	111	P01584
DLDHTLCRYNLPESA	NT5DC1	16	Q5TFE4
QTIRDNLYRHAVPCT	MAGI1	131	Q96QZ7
TEVDCYSRGQAFHPQ	LRIG1	936	Q96JA1
RHQELPDCYDFTLTI	MCOLN3	231	Q8TDD5
TPYNFSEHCQDSVDV	NPY4R	26	P50391
HDLYCNTRRSVEAPT	GEMIN8	176	Q9NWZ8
CSSYERSSNAREPHL	NAB1	111	Q13506
YTCVAHNPAGEDARL	HMCN2	3296	Q8NDA2
PEDQCTVTRTYLFLH	LMBRD1	471	Q9NUN5
DPGTVYQCVVRHASL	NCR3LG1	221	Q68D85
QESDRHPNVLRYFCT	ERN2	566	Q76MJ5
QYHERQCRSSPDLLS	FRMD7	331	Q6ZUT3
VDHTLQQYSPEILAC	HPS5	761	Q9UPZ3
TCQHYTVREEAQKTP	LBHD1	251	Q9BQE6
QRVSCAHIYSALDPT	DDX54	361	Q8TDD1
TTYNVADPRRFHCLT	GSX2	176	Q9BZM3
DQIFRYVHDPECVAT	FBXO3	266	Q9UK99
EHSPIRFCTQNGDYI	PER3	336	P56645
YSQEERHKALPTCIS	OR4A16	226	Q8NH70
SIDRYVAVCNPLHDS	OR51G1	121	Q8NGK1
EVTLRPTDSQSHCYR	PCDHGC5	761	Q9Y5F6
QRITSPVHVSFYVCN	NFATC1	666	O95644
RLLSVSAHQDVSYPC	COL11A2	1641	P13942
AASEAPQDVTYAQLH	LILRB2	551	Q8N423
VTVSPNAAHLYCIAA	MFSD2B	221	A6NFX1
RTHSSYCSDPNLVLD	EXOC6B	386	Q9Y2D4
AVCVSPDHDIYLAAQ	KBTBD7	386	Q8WVZ9
YAHRISASNAVCAPL	MED4	151	Q9NPJ6
CHDRNVVTIFSAPNY	PPP2CB	251	P62714
CHDRNVVTIFSAPNY	PPP2CA	251	P67775
LENVVSQYTHPCVLD	IP6K3	201	Q96PC2
RHYCTVANPVSRDAQ	MVP	56	Q14764
PRAQVSDSATYTCHV	HMCN1	1606	Q96RW7
RYESHPVCADLQAKI	CHCHD3	176	Q9NX63
EAHPLVASVCNAYEK	PLIN1	46	O60240
NVTTCNDYVALVHPD	EIF6	106	P56537
CYPHFTCAVDTENIR	GNAL	346	P38405
TCQLYPNAIASTLVH	PAPOLA	256	P51003
CNEEHPAYLASDEIT	OPA1	801	O60313
LSHLVSYANSCVNPI	GALR2	276	O43603
KTLQEHPSLAYCEDR	FRMD4B	211	Q9Y2L6
NRLAHVSEPSTCVYA	GNPTG	146	Q9UJJ9
VSCLVDHRGNITEYQ	GLG1	201	Q92896
PRNYVVTDHGSCVRA	EGFR	296	P00533
DYLNLQCPRHSTISV	EVA1C	71	P58658
PSNLEKETTHRYCAN	ABCE1	76	P61221
RLQAQDAGIYECHTP	IGSF8	116	Q969P0
LYTASQACLQHPDVA	CTNNA1	221	P35221
YTCVVAHEALPNRVT	IGHM	411	P01871
LRESDEHPNVIRYFC	ERN1	616	O75460
VASHCLPQKDLYTAE	CHD6	51	Q8TD26
AESTAVCRAQGDPHY	FCGBP	466	Q9Y6R7
ENVCYDAFAPLSHVR	GJC1	61	P36383
LLYLQSHCDVPADRD	FUT11	211	Q495W5
NETRYPHSVAKSQCL	GUSB	631	P08236
DSHCQERPSEYIATI	CYP4F12	211	Q9HCS2
QSVCSDIFPHIDETY	CNR1	261	P21554
RNEIPFLCHSSTDYA	FAM169A	131	Q9Y6X4
CTLSVYRQLHNSLDP	LUZP1	1031	Q86V48
RQVIHDAYLPCTLAS	GPR142	426	Q7Z601
LANVENVFHPVECSY	DTNA	231	Q9Y4J8
QSRPVQHLIYKDCSD	FGL2	201	Q14314
YPQLSAVIECADSAH	GMPR	196	P36959
ADVSQYPVNHLVTFC	EPS8L1	31	Q8TE68
LHRAVQCTSDYPEHV	SART3	531	Q15020
PQYCHLGRDVTSQLD	SLC15A5	271	A6NIM6
TANLYHCLIDADIPV	SACS	3076	Q9NZJ4
SPLHIAARENRYDCV	EHMT1	941	Q9H9B1
CDLTPTYLNQEDAVH	CPOX	281	P36551
DLQTIHSRELPDCYV	MCOLN2	231	Q8IZK6
HSRELPDCYVFQNTI	MCOLN2	236	Q8IZK6
LIQAEHSYSLCEEPR	CREB3L2	76	Q70SY1
ANRTHCPIYLVNVSS	DPYSL5	236	Q9BPU6
AVCISPDHDIYLAAQ	KBTBD6	386	Q86V97
RSDAEPENHVVVSYC	LIFR	936	P42702
NRAHYFTSICVEPEV	PKD1	1366	P98161
YNTALRLCPTHADSL	OGT	316	O15294
NTATACAPVSHYRAV	PHAX	46	Q9H814
CAPVSHYRAVESVDS	PHAX	51	Q9H814
HPTKLTYDEAVQACL	HAPLN1	266	P10915
IELDPQSSNLYSCHV	MR1	266	Q95460
LDPCDVHLQAASYSV	OTOG	696	Q6ZRI0
CHITADRKVYPQADT	FUT3	91	P21217
DNTPSLSKYNCREVH	SYDE2	556	Q5VT97
HANPECRYVASSSKD	NLE1	211	Q9NVX2
PHELVAQSRNSYVEA	STARD13	871	Q9Y3M8
AQSRNSYVEAEIHVP	STARD13	876	Q9Y3M8
QVKHRCVTDPAYEDV	XAB2	81	Q9HCS7
APEVISAHDYSQQCD	STK33	291	Q9BYT3
ISYRAPELFSVQSHC	STK16	196	O75716
QEDLVPCASLDHYSR	SSPOP	36	A2VEC9
HSTATILNPQDTYCR	NXPE2	111	Q96DL1
KTIVQDYICSPHAES	RASGRF2	226	O14827
EAAFIYNDPTLEVCH	TAF2	81	Q6P1X5
YNDPTLEVCHSESKQ	TAF2	86	Q6P1X5
DVVHEAQEPCSLLYA	OPLAH	526	O14841
SHLCSELEDYVRTPV	LAMA1	1156	P25391
ATVDRVLSAYEPNDH	PPM1J	441	Q5JR12
RLFEASDPYQVHVCN	POLR2B	1106	P30876
NSFVLEQHEYTEPTC	SIPA1L1	1226	O43166
RPHCIVSVNYVLTDT	SIM1	321	P81133
GTANHLDACRVAPYV	SHOX	186	O15266
DHAYLRRSPDQCSSQ	SHROOM3	206	Q8TF72
DNTYTCLVPEFVHSI	TANC1	511	Q9C0D5
DNAYTCLVPEFVHNV	TANC2	461	Q9HCD6
PSEAQCVIYHELQLS	SH3TC1	1001	Q8TE82
VRSHVDVPLSYCNSE	SLCO1B7	401	G3V0H7
NPEVGYCRDLSHIAA	TBC1D3L	181	B9A6J9
QERSDSPEICHYEKS	RGMA	136	Q96B86
RLSNISHLNYCEPDL	B3GNT2	86	Q9NY97
SHLNYCEPDLRVTSV	B3GNT2	91	Q9NY97
IVHDTSEAVELCPAY	AKAP17A	6	Q02040
HCQDYRSELLFPSDV	NCAPH	266	Q15003
DAVRAYEPCIVVSNS	C12orf56	31	Q8IXR9
YEPCIVVSNSENHIL	C12orf56	36	Q8IXR9
APLVDHLEEYNTTCH	TMEM156	146	Q8N614
NPEVGYCRDLSHIAA	TBC1D3B	181	A6NDS4
NPEVGYCRDLSHIAA	TBC1D3H	181	P0C7X1
NAVHRVCLPDASYEF	TMPRSS11E	291	Q9UL52
HLNKVCPTTETIYND	UBA6	541	A0AVT1
SSLNCYVRVDSEHKP	ZNF441	116	Q8N8Z8
NAIQFLASVCERPHY	CSE1L	316	P55060
YNSTIQESLHRSECP	TMPRSS13	291	Q9BYE2
QESLHRSECPSQRYI	TMPRSS13	296	Q9BYE2
RTCAYTNHTVLPEAL	PYGM	371	P11217
HCSAQLYVEEPRTAA	SPEG	1146	Q15772
SIYHVFQSRKDCVDP	SLC52A1	431	Q9NWF4
TVANPQSCHSDRVYQ	SLC2A4RG	306	Q9NR83
LHQTPDSQVYLSIAC	TBC1D8B	66	Q0IIM8
NPEVGYCRDLSHIAA	TBC1D3F	181	A6NER0
RHEVTICNYEASANP	PITHD1	181	Q9GZP4
PAAQYCLQRVTEARH	TRABD	361	Q9H4I3
NEYPVILSIENHCSV	PLCH2	411	O75038
VECPFEQDASITHYL	RASGEF1C	411	Q8N431
PTHEIRCNSEVKYAS	RFLNA	101	Q6ZTI6
NSVASHVDVPLSYCN	SLCO1B3	446	Q9NPD5
PVNLSVFCDHNYTVE	THAP1	126	Q9NVV9
PRSSYHNITDVCELA	PRLR	426	P16471
SSRNTCEHIYEFPQL	UNC119B	196	A6NIH7
SEHPNVVLNSSYVCV	ZHX1	91	Q9UKY1
SERYPCLSEVVKEHQ	XRN1	11	Q8IZH2
ASASFPDECEHVQYV	ZNF654	91	Q8IZM8
PDECEHVQYVLSSLA	ZNF654	96	Q8IZM8
ATQEPVNCTNYTAHV	TM2D1	66	Q9BX74
LDCRHENTSSSPIQY	THY1	36	P04216
CSQRSAQELPHIEKY	NFATC3	591	Q12968
AQELPHIEKYSINSC	NFATC3	596	Q12968
TPYNFSEHCQDSVDV	NPY4R2	26	P0DQD5
KCIDLEPDNATTYVH	TOMM70	501	O94826
ACYAIHTLPTQEEIE	ROS1	1921	P08922
NPEVGYCRDLSHIAA	TBC1D3E	181	A0A087X179
SQDVSLACHAEAYPA	IGSF9	241	Q9P2J2
VYECERSDVQIHVPT	PRKRA	51	O75569
IREQYVLTHCSASPE	VWA5B2	661	Q8N398
QYRCHPAISAIANDL	ZGRF1	1876	Q86YA3
ILDPNDHSAVYRCLE	ZNF462	876	Q96JM2
HTPQSASAACEEIAY	ZNF236	1621	Q9UL36
HNFPRYEITVTLQCA	SUOX	251	P51687
NPEVGYCRDLSHIAA	TBC1D3D	181	A0A087WVF3
NERLKTDQHTSYPCS	ZFAND1	51	Q8TCF1
VYFSQEECVTLHPAQ	ZNF597	21	Q96LX8
VPLEDHSSTRAYQAQ	VSIG10L	846	Q86VR7
VIVDTTICDPHYNLA	GTF3C1	1001	Q12789
CTGQREPTYQLNIHD	UBR4	4946	Q5T4S7
NPEVGYCRDLSHIAA	TBC1D3G	181	Q6DHY5
NPEVGYCRDLSHIAA	TBC1D3	181	Q8IZP1
QAALHVPYATINTSC	PVRIG	226	Q6DKI7
LPNDSIHCERELYQS	SULF1	621	Q8IWU6
RHTDTTYFQEPCGIQ	TMLHE	241	Q9NVH6
TDVSCRHNPIYVTRV	TGM6	206	O95932
NPEVGYCRDLSHIAA	TBC1D3K	181	A0A087X1G2
NPEVGYCRDLSHIAA	TBC1D3I	181	A0A087WXS9
NPEVGYCRDLSHIAA	TBC1D3C	181	Q6IPX1
PAHDSKQRLDSISYC	ZMAT1	471	Q5H9K5
ITASHPRDSAVYICA	TRAV41	96	A0A0B4J266
KEPDNHVYTRAAVAA	GGT1	31	P19440
HDNECPIVHRSAYDA	AGL	626	P35573
DAPASNHCSRLLDYV	KLHL1	656	Q9NR64
CLPDQSDVIHARQAY	NEB	2876	P20929